Covidien Ltd. (NYSE: COV, BSX: COV) will report second-quarter
results before trading begins on May 6, 2008. The Company will hold a
conference call for investors at 8:30 a.m. ET. The call can be
accessed in the following ways:
-- At Covidien´s website: http://investor.covidien.com
-- By telephone: For both "listen-only" participants and those
participants who wish to take part in the question-and-answer
portion of the call, the telephone dial-in number in the U.S.
is 800-322-5044. For participants outside the U.S., the
dial-in number is 617-614-4927. The access code for all
callers is 80983121.
-- Through an audio replay: A replay of the conference call will
be available beginning at 10:30 a.m. on May 6, 2008, and
ending at 11:59 p.m. on May 13, 2008. The dial-in number for
U.S. participants is 888-286-8010. For participants outside
the U.S., the replay dial-in number is 617-801-6888. The
replay access code for all callers is 33653329.
ABOUT COVIDIEN
Covidien is a leading global healthcare products company that
creates innovative medical solutions for better patient outcomes and
delivers value through clinical leadership and excellence. Covidien
manufactures, distributes and services a diverse range of
industry-leading product lines in four segments: Medical Devices,
Imaging Solutions, Pharmaceutical Products and Medical Supplies. With
2007 revenue of nearly $9 billion, Covidien has more than 43,000
employees worldwide in 57 countries, and its products are sold in over
130 countries. Please visit www.covidien.com to learn more about our
business.
